Healthy AdultNCT07466264
Contactless Human-Machine-Interface Based on Magnetometers for Consumer Applications
A study testing Magnetoencephalography using quantum-based magnetometers in people with Healthy Adult, run by Robert Bosch GmbH at 1 site in Germany.
Trial summary
This study explores the use of novel, highly sensitive quantum-based magnetometers for creating a contactless human-machine interface for consumer applications. These sensors can detect extremely weak biomagnetic fields, such as those from the brain's neural activity (magnetoencephalography), at room temperature. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Healthy Adult
- What is being tested?
- Magnetoencephalography using quantum-based magnetometers
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 5 participants
- Where
- 1 siteGermany
- Study dates
- 21 Jun 2024to 1 May 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Are at least 18 years of age.
- Are right-handed with normal or corrected vision.
- Are employees of Robert Bosch GmbH and are participating in this study during their working hours.
- They have no acute physical or psychological impairments. They are self-sufficient and have the legal capacity to consent.
- They have provided written consent to participate in the study and for their data to be processed, and have not withdrawn this consent.
Who cannot join
- Pregnancy
- Known cardiological, neurological, or psychiatric pre-existing conditions, especially epilepsy, claustrophobia, agoraphobia.
- Metal-containing prostheses or pacemakers.
- Inability to lie still for several minutes.
- Body weight of more than 99 kg.
Trial locations and contacts
1 site in 1 country.
Germany1 site
Robert Bosch Gmbh, Corporate Sector Research and Advance Engineering
Renningen, Baden-Wurttemberg, 71272
About this study
This study explores the use of novel, highly sensitive quantum-based magnetometers for creating a contactless human-machine interface for consumer applications. These sensors can detect extremely weak biomagnetic fields, such as those from the brain's neural activity (magnetoencephalography), at room temperature. The research aims to quantify interfering biological signals and evaluate the system's performance in detecting user intention for a simple use case. The results will serve as a foundation for developing future applications.
- Conditions
- Healthy Adult
- Being tested
- Magnetoencephalography using quantum-based magnetometers
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Magnetoencephalography using quantum-based magnetometersDevice
Detection of extremely weak biomagnetic fields from the brain's neural activity (magnetoencephalography), to quantify interfering biological signals and evaluate the system's performance in detecting user intention for a simple use case.
| Study group | Role | What they receive |
|---|---|---|
| Motor imagery and Steady State Evoked Potentials | Experimental | internal simulation of an arm movement without execution and periodic visual stimulus Receives: Device: Magnetoencephalography using quantum-based magnetometers |
What is being measured
The primary outcome is the main question the study is designed to answer.
Amplitudes of acquired MEG signals
Measured: 1 hour
Secondary outcomes (2)
Ratio of MEG signal to ambient noise level
Measured: 1 hour
Modulation of magnetic power spectral density
Measured: 1 hour
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Mar 2026
- Study start21 Jun 2024
- Primary completion1 May 2026
- Study completion1 May 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Healthy AdultStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 5 participants (actual)
Sponsor and investigators
- Lead sponsor
- Robert Bosch GmbH
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Eckhard Wehrse, MD, Principal investigator, Robert Bosch GmbH
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07466264
- Sponsor's protocol ID
- HMI-OPM-1
- Status last verified
- May 2026
- First submitted
- 11 Feb 2026
- Last updated
- 22 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Contactless Human-Machine-Interface Based on Magnetometers for Consumer Applications
- ClinicalTrials.gov ID
- NCT07466264
- Acronym / sponsor ID
- HMI-OPM-1
- Conditions
- Healthy Adult
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 5 participants (actual)
- Lead sponsor
- Robert Bosch GmbHIndustry (pharma, biotech, devices)
- Study start
- 21 Jun 2024 (actual)
- Primary completion
- 1 May 2026 (actual)
- Study completion
- 1 May 2026 (actual)
- First posted
- 12 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study explores the use of novel, highly sensitive quantum-based magnetometers for creating a contactless human-machine interface for consumer applications. These sensors can detect extremely weak biomagnetic fields, such as those from the brain's neural activity (magnetoencephalography), at room temperature. The research aims to quantify interfering biological signals and evaluate the system's performance in detecting user intention for a simple use case. The results will serve as a foundation for developing future applications.
Study design
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Motor imagery and Steady State Evoked Potentials | Experimental | Device: Magnetoencephalography using quantum-based magnetometersinternal simulation of an arm movement without execution and periodic visual stimulus |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Are at least 18 years of age.
- Are right-handed with normal or corrected vision.
- Are employees of Robert Bosch GmbH and are participating in this study during their working hours.
- They have no acute physical or psychological impairments. They are self-sufficient and have the legal capacity to consent.
- They have provided written consent to participate in the study and for their data to be processed, and have not withdrawn this consent.
Key exclusion criteria (5 listed)
- Pregnancy
- Known cardiological, neurological, or psychiatric pre-existing conditions, especially epilepsy, claustrophobia, agoraphobia.
- Metal-containing prostheses or pacemakers.
- Inability to lie still for several minutes.
- Body weight of more than 99 kg.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Magnetoencephalography using quantum-based magnetometersDetection of extremely weak biomagnetic fields from the brain's neural activity (magnetoencephalography), to quantify interfering biological signals and evaluate the system's performance in detecting user intention for a simple use case. | Device | Motor imagery and Steady State Evoked Potentials |
Primary outcome
Amplitudes of acquired MEG signals
Time frame: 1 hour
2 secondary outcomes
Ratio of MEG signal to ambient noise level
Time frame: 1 hour
Modulation of magnetic power spectral density
Time frame: 1 hour
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 May 2026.
- Individual participant dataSharing planned: No
Related trials for Healthy Adult
RecruitingPhase 3
Weight Gain Prevention in Adolescents and Young Adults
Healthy Volunteers
Not yet recruiting
Contribution of Corticospinal and Reticulospinal Mechanisms to Neural Adaptations Induced by Muscle Strengthening of Healthy Adults
Healthy Volunteers, Resistance Training Adaptation
Not yet recruitingPhase 1
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Tacabrutideg (BGB-16673) in Participants With Moderate and Severe Hepatic Impairment
Hepatic Impairment, Healthy Adult Participants
Recruiting
Assessing Blood Pressure Variability in a Healthy Adult Population During Transcutaneous Hypoglossal Nerve Stimulation With the Zeus Sleep Device
Transcutaneous Hypoglossal Nerve Stimulation
Recruiting
Effects of Breathing Exercises on Cognition in Older Adults
Older Adults (65 Years and Older), Cognition
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Eckhard Wehrse, MD principal investigator
Robert Bosch GmbH
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Magnetoencephalography using quantum-based magnetometers in people with Healthy Adult, run by Robert Bosch GmbH at 1 site in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Amplitudes of acquired MEG signals (time frame: 1 hour). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2026.